The Harold C. Simmons Cancer Center at the University of Texas Southwestern Medical Center in
Dallas is the only NCI–designated cancer center in north Texas. UT Southwestern is able to provide
access to innovative treatments available at NCI–designated cancer centers for patients living in
much of the central United States, including: Oklahoma and southern Kansas; western Arkansas,
Mississippi and Louisiana; eastern New Mexico and Colorado; and central and west Texas.
Simmons Cancer Center integrates cancer research, clinical cancer care, and cancer control
outreach across UT Southwestern University Hospitals and clinics, Parkland Health and
Hospital System, and Children’s Medical Center Dallas. It has 202 members from 30
departments and centers campus–wide who are leaders in their fields.
Through their work in trans–disciplinary teams, cancer center members promote
innovations in cancer diagnosis, treatment, and control and are currently involved in
488 studies. Their efforts build on UT Southwestern’s longstanding tradition of
scientific discovery, distinguished by four Nobel Prize winners, including three
who are active as faculty, and its notable reputation for excellence in
clinical training. UT Southwestern’s faculty also includes 19 members
of the Institute of Medicine and 18 members of the National Academy of Sciences.
In 2009, UT Southwestern physicians provided care for 2,277 new patients with cancer diagnoses at
UT Southwestern clinics and hospitals, plus 1,853 new patients at Parkland Hospital and Children’s
Medical Center. At the time of its designation as an NCI Cancer Center, Simmons Cancer Center had
114 active clinical trials and studies.
Research and training grants at Simmons Cancer Center total $89 million annually and include funding
by NCI, NIH, ACS, and DoD. UT Southwestern is also one of the leading recipients of grants from CPRIT,
the Cancer Prevention and Research Institute of Texas. In the first half of 2010, the medical center
garnered more than $34 million in CPRIT grants.
 |
